Skip to content

Clinical trials

Expanded access trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Switzerland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available13
Approved for marketing8
Available3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer3
Amgen2
Bayer2
Eli Lilly and Company2
Boehringer Ingelheim1
Center Trials & Treatment1
Gilead Sciences1
Janssen-Cilag International NV1
MaaT Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
HIV Infections2
Acquired Immunodeficiency Syndrome1
COVID-191
Carcinoma, Medullary1
Colonic Neoplasms1
Colorectal Neoplasms1
Dermatitis, Atopic1

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.